Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes
- 1 November 2016
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 438, 51-58
Abstract
No abstract availableKeywords
Funding Information
- Alliance for Lupus Research
- National Institutes of Health (R01105550DK)
This publication has 25 references indexed in Scilit:
- Inhibition of System Xc− Transporter Attenuates Autoimmune Inflammatory DemyelinationThe Journal of Immunology, 2015
- Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphomaJournal of Hematology & Oncology, 2014
- The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2013
- Activated human CD4+ T cells express transporters for both cysteine and cystineScientific Reports, 2012
- Differential Dependence on Cysteine from Transsulfuration versus Transport During T Cell ActivationAntioxidants & Redox Signaling, 2011
- Redox Remodeling Allows and Controls B-Cell Activation and DifferentiationAntioxidants & Redox Signaling, 2010
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain TumorsJournal of Neuroscience, 2005
- Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells.2004
- Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activationProceedings of the National Academy of Sciences, 2002